| Is the prognostic nutritional index a prognostic and predictive factor in metastatic non-small cell lung cancer patients treated with first-line chemotherapy? Y Bozkaya, O Köstek, A Sakin, DT Özyükseler, T Şakalar, İ Çil Supportive Care in Cancer 28, 2273-2282, 2020 | 21 | 2020 |
| Impact of systemic inflammatory markers in patients with ALK-positive non-small cell lung cancer treated with crizotinib OF Olmez, A Bilici, P Gursoy, E Cubukcu, A Sakin, T Korkmaz, I Cil, ... Pulmonology 29 (6), 478-485, 2023 | 7 | 2023 |
| Hepatitis B reactivation rate is higher undergoing some cytotoxic chemotherapy in patients with solid tumors: a large retrospective study M Karaca, D Tural, E Akar, İ Çil, S Bayrak, G Ozet, OK Yucel, E Hocaoglu, ... Chemotherapy 63 (5), 247-252, 2019 | 7 | 2019 |
| Complete response to crizotinib in a patient with adenocarcinoma of the lung cancer harboring c-MET amplification. I Cil, A Zirtiloglu, N Saydam, D Tural Journal of BU ON.: Official Journal of the Balkan Union of Oncology 22 (1 …, 2017 | 6 | 2017 |
| Psychological impacts of COVID-19 pandemic in cancer patients on active treatment S Koca, E Koca, IN Okten, FFC Orengül, A Oztürk, M Ozçelik, A Oyman, ... Heliyon 8 (8), 2022 | 5 | 2022 |
| What are the optimal treatment modalities according to age group in gastric cancer patients A Zirtiloglu, I Cil, VF Mehmet, D Tural J Buon 22, 312-319, 2017 | 5 | 2017 |
| Cytoreductive surgery versus systemic chemotherapy alone in isolated peritoneal carcinomatosis of colorectal origin M Ozcelik, A Oyman, I Cil, O Duzgun, OF Ozkan, M Ayhan Age 31, 1308-1313, 2021 | 4 | 2021 |
| Long-lasting response with polycythemia to third-line axitinib treatment in metastatic renal cell carcinoma: very rare case presentation O Dulgar, I Cil, A Zirtiloglu, D Tural Journal of Oncology Pharmacy Practice 25 (6), 1512-1515, 2019 | 3 | 2019 |
| Effect of adjuvant chemotherapy in stage III cervical cancer patients treated with concurrent chemoradiation: A multicenter study MM Atci, B Akagunduz, M Demir, B Dönmez Yilmaz, T Akin Telli, O Can, ... Oncology Research and Treatment 45 (5), 254-261, 2022 | 2 | 2022 |
| Efficacy and safety of trastuzumab emtansine in older patients with HER2-positive advanced breast cancer: a real-world study I Cil, A Kucukarda, MM Atcı, S Secmeler, N Paksoy, F Ferhatoglu, N Ak, ... Tumori Journal 108 (1), 19-25, 2022 | 2 | 2022 |
| Assessment of abuse and related factors in older patients with cancer B Akagunduz, Z Altın, MM Atcı, M Ozer, DC Güven, İ Çil, F Özçiçek, ... Supportive care in cancer 29 (12), 7957-7964, 2021 | 2 | 2021 |
| An advanced c-MET-amplified NSCLC patient that was treated with crizotinib M Yilmaz, SG Mese, I Cil, A Zirtiloglu Journal of Oncology Pharmacy Practice 26 (2), 474-477, 2020 | 2 | 2020 |
| Sunitinib versus pazopanib for patients with metastatic renal cell carcinoma: two Turkish hospital experience, a retrospective comparative case series study M Ekenel, E Aydin, I Cil, A Zirtiloglu, D Tural, S Karabulut Annals of Oncology 28, v313, 2017 | 2 | 2017 |
| What is the optimal treatment of metastatic hepatocellular carcinoma after complete resection; case presentation of ovarian metastasis. I Cil, A Zirtiloglu, MF Velibeyoglu, D Tural Journal of BU ON.: Official Journal of the Balkan Union of Oncology 22 (2 …, 2017 | 2 | 2017 |
| Time to castration resistance as a predictor of response to docetaxel in metastatic castration resistance in prostate cancer İ Gültürk, GŞ Erdal, GB Sönmezoz, M Yılmaz, SY Tacar, A Özmen, ... Istanbul Medical Journal= Istanbul Tip Dergisi 23 (4), 269, 2022 | 1 | 2022 |
| Impact of Breast Cancer Subtypes on Pathological Complete Response Following Neoadjuvant Chemotherapy A Oyman, M Ozcelik, I Cil Eurasian Journal of Medical Investigation 6 (2), 147-150, 2022 | 1 | 2022 |
| Sunitinib versus pazopanib para el tratamiento del carcinoma de células renales metastásico: experiencia en 2 hospitales turcos M Ekenel, S Karabulut, I Cil, A Zırtıloglu, E Aydın, D Tural Actas Urológicas Españolas 44 (1), 27-33, 2020 | 1 | 2020 |
| Sunitinib versus pazopanib for patients with metastatic renal cell carcinoma: 2 Turkish hospital experience M Ekenel, S Karabulut, I Cil, A Zırtıloglu, E Aydın, D Tural Actas Urológicas Españolas (English Edition) 44 (1), 27-33, 2020 | 1 | 2020 |
| Major and minor salivary gland cancers: A multicenter retrospective study MB Hacioglu, B Erdogan, M Bardakcı, E Algın, B Gulbagcı, I Hacibekiroglu, ... Head & Neck 45 (7), 1643-1653, 2023 | | 2023 |
| The impact of adjuvant oxaliplatin and tumor sidedness on the overall survival of stage IIB colon cancer patients: a multicentre study MM Atci, B Akagunduz, M Demir, R Arikan, S Ay, M Ozer, M Ayhan, I Cil, ... Journal of Chemotherapy 35 (1), 19-28, 2023 | | 2023 |
